KIAWAH ISLAND, S.C. — Povicaine, launched in late 2024, has “become a staple in our practice,” Brandon D. Ayres, MD, said in this Healio Video Perspective from Kiawah Eye.
Ayres, who practices in the greater Philadelphia area at Wills Eye Hospital and Ophthalmic Partners, uses Povicaine (povidone-iodine 1.25% and proparacaine 0.5%, ImprimisRx) in procedures such as collagen cross-linking, superficial keratectomy, lamellar keratectomy and suture removal.
“It keeps our patients comfortable for longer than they need [to be] for the procedures, and I’m not worried